Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
10 /100
LOW RISK
Score updated Oct 13, 2026

NBIX — Neurocrine Biosciences, Inc. Dilution Risk Tracker

Track NBIX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NBIX — Get alerts when the score changes →

As of October 13, 2026, Neurocrine Biosciences, Inc. (NBIX) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. Neurocrine Biosciences, Inc. has a market capitalization of $14.37B, 101.65M shares outstanding, 698 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰Cash Runway—
📊 Float Risk
5
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for NBIX.
🔔 Track NBIX — Get forecast alerts →

Market Data

Market Cap$14.37B
Shares Outstanding101.65M
Float99.28M
Cash$585.05M
Debt$463.50M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore10/100DilutionWatch score record
Shares Outstanding101.65MVerified float table or market cache
Public Float99.28MVerified float table or market cache
Market Cap$14.37BMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 3 1, 4 4, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 10.6% shares (2026Q1 vs prior)
698 institutional holders · 113.75M shares
#1 BlackRock, Inc. 13.39M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 9.02M shares
#3 Dodge & Cox 5.46M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.85M
Days to Cover4.0
% of Float5.9%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2020-02-07
3 FORM3 2026-03-17
4 INSIDER TRANSACTION 2026-03-05
4 INSIDER TRANSACTION 2026-02-23
4 INSIDER TRANSACTION 2026-02-17
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual NBIX Dilution Snapshot

Neurocrine Biosciences, Inc. (NBIX) has a DilutionScore of 10/100, rated Low dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

NBIX's DilutionScore has held steady at 10/100 (Low risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202610/100LOW89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

NBIX shares outstanding have decreased 0.0% from 100.55M (May 2026) to 100.55M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 23, 2026100.55M99.28M▲ 0.02%
May 08, 2026100.55M99.26M▲ 0.19%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track NBIX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment NBIX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking NBIX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NBIX
NBIX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.